Factors predicting poor outcomes of patients treated with tocilizumab for COVID‑19‑associated pneumonia: A retrospective study-Reference-Cited by-同舟云学术

Factors predicting poor outcomes of patients treated with tocilizumab for COVID‑19‑associated pneumonia: A retrospective study

Published:2022-10-20 Issue:6 Volume:24 Page:
ISSN:1792-0981
Container-title:Experimental and Therapeutic Medicine
language:
Short-container-title:Exp Ther Med

Author:

Georgakopoulou Vasiliki¹,Basoulis Dimitrios¹,Voutsinas Pantazis¹,Makrodimitri Sotiria¹,Samara Stamatia¹,Triantafyllou Maria¹,Eliadi Irene¹,Karamanakos Georgios¹,Papageorgiou Chrysovalantis²,Anastasopoulou Amalia³,Bitsani Aikaterini⁴,Kampouropoulou Olga¹,Eleftheriadou Ioanna¹,Gkoufa Aikaterini³,Spandidos Demetrios⁵,Papalexis Petros⁶,Sipsas Nikolaos¹

Affiliation:

1. Infectious Diseases and COVID‑19 Unit, Laiko General Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece

2. Pulmonology Department, Laiko General Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece

3. First Department of Internal Medicine, Laiko General Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece

4. First Department of Propedeutic Internal Medicine, Laiko General Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece

5. Laboratory of Clinical Virology, School of Medicine, University of Crete, 71003 Heraklion, Greece

6. Unit of Endocrinology, First Department of Internal Medicine, Laiko General Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece

Publisher

Spandidos Publications

Subject

Cancer Research,Immunology and Microbiology (miscellaneous),General Medicine

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The parallel lives of pandemics: COVID‑19 and obesity;Experimental and Therapeutic Medicine;2024-03-06

2. A mid‑pandemic night's dream: Melatonin, from harbinger of anti‑inflammation to mitochondrial savior in acute and long COVID‑19 (Review);International Journal of Molecular Medicine;2024-01-26

3. Impact of comorbidities and inflammatory markers on mortality of COVID-19 patients;Lung India;2024

4. Early 3‑day course of remdesivir for the prevention of the progression to severe COVID‑19 in the elderly: A single‑centre, real‑life cohort study;Experimental and Therapeutic Medicine;2023-08-09

5. Predictors of COVID‑19‑associated mortality among hospitalized elderly patients with dementia;Experimental and Therapeutic Medicine;2023-07-03